Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Korean College of Rheumatology
Days
Hrs
Mins
Register now
Search

Hanlim Pharm

Hanlim Pharm

Hanlim Pharmaceutical is a leading Korean pharmaceutical company committed to improving patients’ lives through innovative therapies. Through its specialized Immunology Division, Hanlim focuses on advancing care for patients with immune-mediated and rheumatic diseases, fostering scientific collaboration and delivering high-quality treatment solutions that improve patient outcomes and quality of life.

Share

Key dates

Registrations
  • Early bird
    9 June 2026 EXTENDED 23 June 2026
  • Standard
    10 June to 28 September 2026
  • Late
    29 September to 1 November 2026
Abstracts
  • Submissions open
    3 September 2025 to 11:59PM AEST, 22 May 2026 CLOSED
  • Abstract acceptance notification
    mid-July 2026
  • Late abstract submissions open
    TBC
  • Late abstract submissions notification
    TBC
  • APLAR 2026 Congress
    28 October - 1 November 2026
  • Example
    Old date strike out EXTENDED
    Old date strike out CLOSED

More Partners / Exhibitors

Onco-Bio
MDPI
Association of Women in Rheumatology
Takeda
CESAS Medical
Hanlim Pharm
Hanlim Pharm
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Tuesday 23 June, 2026

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

REGISTER NOW
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

SUBMIT NOW